New drugs to treat children with aggressive cancers will be fast-tracked into clinical trials thanks to $2 million awarded to the Children’s Cancer Institute.
Researchers from UNSW and the Children's Cancer Institute Australia have developed a new approach to the treatment of acute myeloid leukaemia (AML), one of the most aggressive forms of the disease.
